NCT00518011View on ClinicalTrials.gov

A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer.

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Non-Squamous Non-Small Cell Lung Cancer

Interventions

DRUG

Erlotinib

150 mg po daily

DRUG

Gemcitabine

As prescribed

Trial Locations (14)

2031

Randwick

2065

St Leonards

2139

Sydney

2480

Lismore

2500

Wollongong

3002

Melbourne

3011

Footscray

3052

Parkville

3084

Melbourne

3121

Richmond

3690

Wodonga

4032

Chermside

4066

Auchenflower

4120

Greenslopes

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00518011 - A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. | Biotech Hunter | Biotech Hunter